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Abstract 
Aim: An improved understanding of pathophysiology of haemorrhoids has 
resulted in the introduction of new surgical techniques including stapled 
haemorrhoidopexy (SH). This randomised controlled trial compared the 
effectiveness of SH with rubber band ligation (RBL) in the treatment of grade II 
circumferential symptomatic haemorrhoids in the long-term.  
Patients and Methods: A consecutive cohort of patients were randomly allocated 
to either SH or RBL. Data on haemorrhoidal symptoms, Cleveland continence 
scores, sphincter assessment, SF-36, EQ-5D, HAD score and prior treatment 
history were assessed at enrollment and reassessed by long-term postal 
questionnaire. The details were analysed using SPSS 12.0 from Microsoft 
Access. 
Results: Sixty patients were allocated by computer block randomisation. Both 
groups were balanced for age, sex and symptoms. Recurrence was significant, 
favoring SH [3 vs 11; OR 0.18, 95% CI (0.03 to 0.86), p=0.028] at one year and, at 
a mean of 40.67 (31-47) months [4 vs. 12; OR 0.23, 95% CI (0.05, 0.95); 
p=0.039]. SH patients experienced prolonged pain [Median (IQR) = 7 (5,7) vs. 3 
(1,7), P=0.008] and took longer time to return to work [6 (3,7) vs. 3 (1,6) days, 
P=0.018].  No significant difference in quality of life.   
 
Conclusion: SH achieved better disease control at one year without any major 
complication.  This was sustained in the long-term. Further studies with greater 
number of patients are needed to confirm this small study.  
 
 
 
Introduction 
There is a plethora of treatments available for haemorrhoids but no single 
conventional modality combines immediate efficacy, sustained benefit, patient 
acceptability and a low complication rate. Rubber band ligation (RBL) is a 
commonly used, simple and out patient procedure. It is easily repeatable with 
better results compared to other non-operative treatments including injection 
sclerotherapy, cryotherapy, and infrared coagulation1. In spite of its simple nature 
RBL may be associated with a variety of complications including vaso-vagal 
syncope, severe pain, urinary retention, bleeding and more rarely with perineal 
and retroperitoneal sepsis, as well as recurrence of symptoms.
 
2-5 
If outpatient measures fail, the most commonly performed operative procedure is 
excisional haemorrhoidectomy6. This removes the haemorrhoidal tissue, unlike 
RBL, which aims to reduce prolapse with retention of the anal cushion by 
producing sub mucosal fibrosis at its apex. We recently undertook a systematic 
review comparing these two treatments which demonstrated that EH was a more 
effective method of successfully treating grade III haemorrhoids7
 
. This was 
appeared to be achieved at the expense of an increased risk of procedure-related 
potential complications.. No evidence of a statistically significant difference was 
seen in grade II haemorrhoids.  
Improved understanding of the pathogenesis of haemorrhoids8, increasing belief in 
the importance of preserving the anal cushions and greater awareness of the 
complications associated with excisional haemorrhoidectomy lead to the invention 
of newer surgical procedures including stapled haemorrhoidopexy (SH). SH acts 
by relocating the haemorrhoidal cushions cranially into their original position by 
excising a strip of lower rectal mucosa (pain insensitive mucosa) and by 
interrupting the blood supply to the haemorrhoids9.   
A variety of studies have proved the efficacy and safety of SH compared with 
other treatment modalities (RBL, Excisional Haemorrhoidectomy)10-15. Most 
published comparative trials of SH have evaluated the new procedure against 
excisional haemorrhoidectomy. The fundamental difference in the mechanisms of 
action of these two procedures limits the validity of such a comparison. Since the 
introduction of SH there has been only one published randomised controlled trial 
comparing this procedure with RBL in the treatment of grade III and IV 
haemorrhoids.10 In view of the relatively high recurrence rate for symptoms 
following RBL16,17
 
 (frequently adopted for grade II haemorrhoids) and the lack of 
comparative studies against SH, we conducted a pilot study to compare these two 
techniques in a randomised controlled setting.  
Aims 
The aim of the study was to evaluate the effectiveness of SH against conventional 
therapy (RBL) in the treatment of circumferential grade II haemorrhoids. All the 
patients included in the trial were symptomatic and keen for an intervention to 
allay the symptoms.  
 
Patients and methods 
This was a single centre, prospective, pragmatic, open, randomised controlled trial 
with parallel group design, comparing RBL with SH in symptomatic, 
circumferential (haemorrhoids in all the three primary positions with or without 
additional secondary haemorrhoids), prolapsing haemorrhoids that reduce 
spontaneously (grade II) or requiring only occasional manual reduction. The 
primary outcome addressed in this study was disease recurrence at one year and 
the cumulative costs to the NHS. Both subjective and objective evidence of 
disease recurrence were considered before making a conclusion that any 
particular patient had recurrent disease needing further treatment. This study was 
conducted as a pilot study and hence no power calculation performed. Additional 
outcome measures included quality of life [assessed by Short Form-36 (SF-36)18, 
EuroQuol -5D (EQ-5D19) and Hospital Anxiety and Depression scale (HAD score)], 
Quality Adjusted Life Years (QUALY), symptom score20, time to no pain, time to 
normal activity, patient satisfaction, effect on ano-rectal physiology and 
complication rates between the two procedures. A visual analogue scale (VAS) 21
 
 
was used to assess the severity of pain before and for seven days after the 
procedure. The Grampian local research ethics committee approved the conduct 
of the study (Ethics committee approval code – GREC 01/0297). Further long-term 
follow-up was obtained by a postal questionnaire and case notes review (where 
the questionnaire was not returned).  
Inclusion criteria: The study included a consecutive group of patients with 
symptomatic grade II haemorrhoids recruited between October 2002 and March 
2004 without regard for age, sex or duration of symptoms. This cohort included 
symptomatic patients who had previously undergone non-operative treatment for 
haemorrhoids with at least 6 months elapsing prior to recruitment.   
 
Exclusion criteria: Patients with peri-anal sepsis and malignant disease of the 
large bowel were excluded from the trial. Similarly, those with pre-existing 
evidence of sphincter injury were also excluded after appropriate investigations.  
 
Pre-treatment assessment: All trial participants underwent a standardised pre-
operative evaluation of anal sphincter function by an endo-anal ultrasound and 
anal manometry. This assessment was performed prior to randomisation in order 
to facilitate the exclusion of patients with anatomical or functional defects of the 
sphincters. Then, the participants were randomised to one or other of the two 
interventions.  
 
Randomisation: A computerised block randomisation technique was utilised in 
this study. The Health Science Research Unit (HSRU), University of Aberdeen, 
created a computer program to generate a sequence of treatment allocations by 
block randomisation using a random number generator. Investigators were blinded 
to the block size to avoid selection bias. Allocation to treatment was performed on 
the day of the procedure using HSRUs secure automated telephone 
randomisation service.  
 
RBL was performed using the standard suction banding technique. All three 
haemorrhoidal components were treated at one sitting. This was performed in the 
operating theatre but with out anaesthesia. SH was performed using the 
Procedure for Prolapse and Haemorrhoids 01 (PPHTM, Ethicon Endo-Surgery® 
plc, Europe) kit. The patients were placed in prone jack-knife position as this was 
the routine practice of the surgeon. The procedural details are published 
elsewhere12,14
 
. 
Post-procedure evaluation:  Time to no pain and time to return to normal activity 
were recorded for all participants. All the pre-operative data were collected after 
each procedure at 6-weeks, 6-months and 1-year after each procedure 
Proctoscopic examination was carried out at each stage of follow-up to identify 
recurrent disease. Patients who remained symptomatic after intervention could be 
re-treated within the trial protocol. RBL could be attempted four further times, 6-
weeks apart, and SH patients could undergo two further stapling procedure before 
being classified into a complete treatment failure group.    
 
An independent consultant colorectal surgeon, who was blinded to the 
intervention, performed the final follow-up assessment at 52 weeks. The disease 
was considered recurrent if there were both subjective and objective evidence of 
recurrent disease. 
 
Statistical Analysis 
Each comparison was analysed by intention to treat. The outcomes were analysed 
only after the completion of data collection from the final patient at the end of one 
year. Statistical significance for all outcomes was based on the two-sided t-test 
with p ≤ 0.05. Recurrence was compared using a two-sided Fisher’s exact test. 
The distribution of the numbers of days to no pain and return to normal activities 
were skewed and thus analysed using a Mann-Whitney U test. For health-related 
quality of life measures and all other outcomes, the mean difference between 
intervention groups adjusting for baseline values, was estimated using a linear 
regression model. For the long-term follow-up, Mann-Whitney U test for the 
Cleveland and symptom score were performed. All analyses were carried out 
using SPSS 
 
12.0 for Windows and STATA version 9.0.   
 
  
Results 
Of the sixty-nine patients identified with grade II symptomatic circumferential 
haemorrhoids, between October 2002 and March 2004, sixty patients were 
recruited into the study (Fig. 1). There were forty-four male patients. The median 
age was 44 (range 22 to 71) years. The commonest symptom at presentation was 
bleeding (n=56). Details of other haemorrhoidal symptoms were also obtained 
(Table 1).  Reasonable balance was observed at baseline between the two 
treatment groups (Table 2). 
 
All 60 participants received the treatment to which they were allocated. Data for 
three patients in each group was missing at the one-year follow-up for a variety of 
reasons (one patient in the RBL group withdrew before the 3-week follow-up; 
another patient in the stapled group developed Crohn’s disease of the small bowel 
and withdrew after the 6-week follow-up; an additional two patients in each group 
moved out of the area after the 6-month follow-up).  
 
At the 3-week follow-up there was evidence of a lower SF-36 physical component 
score [mean (SD) 47 (7) versus 52 (9); mean difference: -3.5, 95% CI (-7.1 to 0.1); 
p=0.054], for SH. This was not observed for the mental component score [mean 
(SD) 47 (10) versus 49 (10); mean difference: 0.3, 95% CI (-3.6 to 4.2); p=0.883]. 
Similarly, no statistically significant difference was seen with the EQ-5D [mean 
(SD), 0.7 (0.3) versus 0.8 (0.2); mean difference: 0.0, 95% CI (-0.1 to 0.1); 
p=0.665] at 3-weeks.  
 
One patient in the stapled group and 10 in the RBL group had recurrence of 
haemorrhoidal disease at 6-weeks. At one year, there was evidence of a lower 
rate of recurrence of haemorrhoidal disease in the SH group compared to RBL [3 
vs. 11; OR 0.18 95% CI (0.03 to 0.86); p=0.028]. One patient in the stapled group 
received a single re-treatment during the trial period whereas 10 patients in the 
RBL group had one or more (19 in total) further band ligations. There was a trend 
towards better overall symptom scores in the stapled group at the end of the 
follow-up period (Table 3). Nevertheless, this did not achieve statistical difference 
between the two interventions.  
 
A total of 46 out of 60 (77%) questionnaires (24 in SH and 22 in RBL group) were 
returned.  Six patients had dropped out of the trial within the first year, for the 
reasons mentioned above. The case notes and hospital attendance record 
(electronic hospital database) were reviewed for the remaining 8 patients to 
assess if any further treatments had been performed after the one-year follow-up. 
The mean (SD) length of follow-up was 40.67 (±6.26) months. There was a 
statistically significant difference in the disease recurrence favouring SH, 4 vs. 12; 
OR 0.22 95% CI (0.04, 0.92); p=0.035. However, the Cleveland score (mean (SD), 
3 (4) versus 3 (4); mean difference: 0.4, 95% CI (-1.8 to 2.7); p=0.686) and the 
symptom score (mean (SD), 6 (5) versus 7 (5); mean difference: -1.0, 95% CI (-
3.8 to 1.7); p=0.456) did not reveal any significant difference between the two 
procedures. 
   
Two participants developed postoperative retention of urine following SH. One 
patient each had faecal impaction and a fissure-in-ano following SH. Both patients 
were managed appropriately without further consequences. One other patient in 
the stapled group suffered mild symptomatic anal stenosis, which was managed 
conservatively and did not require surgical intervention. Three more patients were 
found to have residual staples at one year. There was no further bleeding in these 
patients once the staples were removed. Among the patients treated with RBL, 
one patient developed a severe post-procedure anal fissure. This did not resolve 
with medical treatment and required examination under anaesthesia and internal 
sphincterotomy. The Cleveland continence score did not reveal a significant 
difference in continence between the procedures over either at 6-weeks [mean 
difference: 0.8 95% CI (-1.6 to 3.5), p=0.166)] or at 52-weeks [mean difference: 
0.8 95% CI (-1.6 to 3.5), p=0.156)]. Moreover no statistically significant differences 
were observed for any of the quality of life measures at one year (Table 3). One 
patient in the stapled group showed ultrasound evidence of minor damage to the 
internal sphincter (this was not reflected on anal pressures or continence). There 
was no other evidence of anatomical or functional damage to the internal or 
external anal sphincters on endo-anal ultrasound or manometry in either cohort. 
 
Pain on the day of the procedure was similar for both groups, 5 (4, 8) vs. 6 (4, 8). 
However, patients took longer to become pain free after the SH procedure 
[median (IQR) - 7 (5,7) (n=30) vs. 3 (1,7) days (n=28); p=0.008] and to return to 
normal activity compared with RBL [6 (3,7) vs. 3 (1,6) days; p=0.018] (Fig.2).   
 
The mean cost per patient treated using stapled haemorrhoidopexy was 
significantly higher than that for RBL (£1620 compared to £252).  Much of this 
difference can be attributed to the initial procedure cost. Based on the recurrence 
at 1-year, an incremental cost per recurrence avoided from stapling 
haemorrhoidopexy was £4560. It was unlikely that stapled haemorrhoidopexy 
would be considered cost-effective at threshold values for society’s willingness to 
pay for a QALY based upon the 12 month data. However, given the finding of 
increased recurrences in the rubber band ligation arm it would be expected that 
the difference in cost would fall over a longer time horizon and that the quality of 
life associated with the rubber band ligation arm would be reduced. The cost 
effective analysis of this comparative study will be presented in a separate paper.  
. 
Discussion: 
Excisional haemorrhoidectomy is considered the ‘gold standard’ for the surgical 
treatment of prolapsing and symptomatic haemorrhoids. This procedure is widely 
perceived as painful with potential  complications22. Such considerations may alter 
treatment-seeking attitude amongst patients, and in particular, may result in 
under-reporting of recurrent or residual symptoms 23
 
.   
The outcome from a variety of studies has shown SH to be equally effective 
compared to excisional haemorrhoidectomy (EH) in the long term24. Initial 
comparative trials involving excision versus stapled procedures have 
demonstrated consistently reduced pain scores in favour of the stapled 
procedure25-27
 
. It can be argued that, as the surgical mechanisms involved in the 
two procedures are so widely different, such comparisons have limited validity.  
The intent and mechanism of SH is similar to that of RBL. The patient population 
was selected in an attempt to get a clinically meaningful group in whom most 
colorectal surgeons would consider RBL rather than immediate surgery. This 
group was also felt most likely to answer the question regarding the place, if any, 
of an earlier definitive treatment (albeit at greater initial expense) in modifying the 
natural history of the disease. If, however, sustained efficacy can be 
demonstrated, the reduced future costs of re-treatment may make this justifiable, 
even if intervention is carried out at an earlier pathological stage. Nevertheless, 
there was greater post-procedure pain and a prolongation of time away from 
normal activity in patients treated with SH. However both groups showed early 
return to normal activity (within one week) and compare favourably with historical 
trials of excisional haemorrhoidectomy. 
 
There are some early and delayed complications reported in the literature for 
SH28-30
 
. No such major complications  were observed in our study in either group. 
Moreover, continued rectal bleeding experienced by some of the patients was 
actually due to residual staples rather than true recurrence of the disease. These 
patients were reassured and followed up after 6-weeks to identify any objective 
evidence of haemorrhoids. Hence, both independent consultant assessment and 
symptoms from patients were considered before any patients were declared to 
have recurrent disease needing further treatment.   
A further concern with regard to SH has been the involvement of internal anal 
sphincter in the rectal doughnut specimen. However this does not appear to 
influence continence or anal symptoms in the long term.20,31 By evaluating 
sphincter anatomy and physiology, this study has again shown no adverse effect 
of either treatment modality. The power of the study was reflected in the 
confidence intervals for the comparison. We cannot exclude the possibility of a 
difference of up to 3.5 in the symptom score at 52 wk and 3.8 at long-term follow 
up. The retrospective power calculation was not performed because it was not 
considered good practice as they merely reflect the result 
(http://www.cs.uiowa.edu/~rlenth/Power/).  
 
 
  
 
Conclusion 
The findings from previous studies of the effectiveness of SH in have been 
confirmed in our study. SH had less recurrence at 1 year than RBL although it was 
associated with a longer post-operative recovery.  The clinical benefit of SH is 
maintained in the long-term. However, there is insufficient evidence about the 
cost-effectiveness of stapled haemorrhoidopexy for grade II haemorrhoids to 
recommend its use in place of rubber band ligation. Additionally, in view of the 
non-significant difference in the symptom score and because of the benign nature 
of the disease, it would be reasonable to perform RBL prior to considering the SH. 
A properly selected cohort of patients would benefit from the treatment with SH. 
The patients should be allowed to make an informed choice considering the 
severity and duration of symptoms. Further studies with greater number of 
patients need to be performed to substantiate the significant difference.  
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 Figure 1 Flow diagram showing the details of trial recruitment 
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Table 1 Symptoms 21
 
 at initial presentation (Number of patients in each group) 
I. Bleeding per rectum  
 None (0) 
Spotting 
(1) 
Dripping 
into pan (2) 
Without 
stool (3) 
Staining 
underwear (4) 
Staple (N) 3 14 10 1 2 
RBL (N) 1 11 11 1 6 
 
 
II. Pain 
 None  (0) 
Only with stool  
(1) 
Constant 
throbbing (2) 
Staple (N) 7 18 5 
RBL (N) 16 10 4 
 
 
III. Other relevant symptoms 
 
Symptom 
Never 
(0) 
Rarely 
(1) 
Sometimes 
(2) 
Often 
(3) 
Always 
(4) 
Staple RBL Staple RBL Staple RBL Staple RBL Staple RBL 
Itching 7 10 6 5 6 10 10 4 1 1 
Mucous discharge 19 24 3 3 3 2 2 0 3 1 
Urgency 10 14 9 7 8 5 2 3 1 1 
Frequency 14 14 3 4 5 8 5 3 3 1 
Prolapse 7 11 3 6 11 5 4 4 5 4 
Table 2 Details of the baseline values between the two groups studied 
  
Variable 
Stapled 
haemorrhoidopexy 
(n=30) 
Rubber band ligation 
(n=30) 
Age (Years) – Median (Range) 49.5 (22 to 70) 40 (30 to 65) 
Sex (M/ F) 23/7 21/9 
ASA grade - Median 2 1 
Previous treatment - Number of patients 5 (1 EH, 1 ST, 3 RBL)* 4 (1EH, 1 ST, 2 RBL)* 
Maximum resting anal Pressure - 
Median (IQR) 93 (54,106) 80 (50,103) 
Cough pressure – Median (IQR) 147 (105,184) 150 (50,194) 
Squeeze pressure – Median (IQR) 180 (138,232) 184 (150,247) 
Symptom score – Mean (SD) 9 (4) 8 (4) 
Cleveland clinic continence score - 
Mean (SD) 3 (3) 2 (3) 
SF–36 score Physical – Mean (SD) 
  Mental – Mean (SD) 
51 (7) 
47 (11) 
53 (9) 
49 (10) 
EQ-5D – Mean (SD) 0.7 (0.2) 0.8 (0.2) 
HAD Anxiety – Mean (SD) 
 Depression – Mean (SD) 
6 (4) 
3 (3) 
6 (4) 
3 (3) 
 
* EH – Excisional haemorrhoidectomy, ST – Sclerotherapy and RBL – Rubber Band Ligation 
 
 
 
  Table 3 Comparison of the results of the two interventions at different time points 
 6-Week 26-Week 52-Week 
 SH RBL SH RBL SH RBL MD  
(95% CI) p-value  
Anal manometry -      
Median, (IQR) 
               MRP 
 
90 (60,101) 
 
75 (50,106) 
 
100 (89,118) 
 
100 (65,120) 
 
99 (89,115) 
 
100 (76,108) 
 
-- 
 Cough 136 (121,148) 
129 
(103,187) 
160  
(134, 190) 
160 
(127,188) 
147  
(132, 184) 
160  
(131, 219) -- 
    Squeeze 172 (136,228) 
171 
(111,231) 
207  
(139, 251) 
195 
(147,246) 
212  
(158, 297) 
215  
(182, 306) -- 
Symptom score  
Mean (SD) 6 (4) 6 (4) 5 (4) 5 (4) 5 (4) 6 (4) -1.6 (-3.5,0.3), 0.092 
Cleveland score  
Mean (SD) 2 (3) 1 (2) 2 (2) 1 (2) 2 (2) 1 (2) 0.8 (-0.3,1.8), 0.156 
SF-36 - Mean (SD)        
          Physical 49 (7) 53 (8) 52 (7) 55 (8) 52(7) 54 (8) -1.2 (-4.7, 2.3), 0.486 
          Mental 50 (9) 52 (9) 51 (8) 52 (7) 50(9) 51 (9) -0.8 (-5.4, 3.8), 0.742 
EQ-5D – Mean (SD) 0.7 (0.2) 0.8 (0.2) 0.8 (0.2) 0.9 (0.2) 0.9(0.2) 0.9 (0.1) 0.0 (-0.1,0.1), 0.758 
HAD score – Mean (SD)        
          Anxiety 6 (4) 5 (4) 5 (4) 5 (4) 6 (4) 5 (4) 0.9 (-0.8,2.5), 0.295 
          Depression 3 (3) 2 (3) 3 (3) 2 (3) 2 (2) 2 (2) 0.5 (-0.6,1.6), 0.356 
 
 MRP - Maximum Resting 
CI – Confidence Interval
Anal Pressure, IQR – Interquartile Range, SD – Standard Deviation, MD – Mean Difference,  
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